Outlook Therapeutics OTLK
NASDAQ OTLK
$0.56 +0.04 (+7.94%)
At close: Oct 21, 2026 · 4:00 PM EDT

Outlook Therapeutics (OTLK) Notes Payables (2015 - 2025)

Updated

Outlook Therapeutics' Notes Payables was $29.95 million in fiscal Q4 2025 (quarter ended Sep 30, 2025).

Analysis

Outlook Therapeutics (OTLK) Notes Payables (2015 - 2025) Analysis & Trends

From fiscal Q4 2015 onward, Outlook Therapeutics has reported Notes Payables for 21 quarters.

  • Notes Payables shows a five-year compound annual growth rate of 52.7% (FY2020 to FY2025).
  • The fiscal Q4 2025 figure marks the highest quarterly Notes Payables in data going back to fiscal Q4 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Outlook Therapeutics 77.51 Mn 41.76 Mn -8,265.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 29.95 Mn
Sep 30, 2020 3.61 Mn
Jun 30, 2020 3.61 Mn
Mar 31, 2020 3.61 Mn
Dec 31, 2019 3.61 Mn
Sep 30, 2019 3.61 Mn
Jun 30, 2019 3.61 Mn
Mar 31, 2019 3.61 Mn
Dec 31, 2018 4.61 Mn
Sep 30, 2018 4.61 Mn
Jun 30, 2018 4.61 Mn
Mar 31, 2018 4.61 Mn
Dec 31, 2017 4.61 Mn
Sep 30, 2017 4.61 Mn
Jun 30, 2017 4.61 Mn
Mar 31, 2017 4.61 Mn
Dec 31, 2016 4.61 Mn
Sep 30, 2016 4.61 Mn
Jun 30, 2016 4.61 Mn
Mar 31, 2016 9.65 Mn
API Access

Outlook Therapeutics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=OTLK&period=max&api_key=YOUR_API_KEY